Page last updated: 2024-08-26

tretazicar and aq4n

tretazicar has been researched along with aq4n in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyle, RG; Travers, S1
Jeavons, M; Lehouritis, P; McCarthy, FO; Stanton, M; Tangney, M1

Reviews

1 review(s) available for tretazicar and aq4n

ArticleYear
Hypoxia: targeting the tumour.
    Anti-cancer agents in medicinal chemistry, 2006, Volume: 6, Issue:4

    Topics: Anthraquinones; Antineoplastic Agents; Aziridines; Benzoquinones; Cell Hypoxia; Clinical Trials, Phase III as Topic; Drug Screening Assays, Antitumor; Humans; Imidazoles; Indolequinones; Neoplasms; Prodrugs; Quinolines; Radiation-Sensitizing Agents; Tirapazamine; Triazines

2006

Other Studies

1 other study(ies) available for tretazicar and aq4n

ArticleYear
Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, Jan-28, Volume: 222

    Topics: Animals; Anthraquinones; Antineoplastic Agents; Aziridines; Bacterial Proteins; Bifidobacterium; Cell Line, Tumor; Drug Delivery Systems; Enzymes; Escherichia coli; Female; Lactobacillus; Lactococcus; Mice, Inbred BALB C; Neoplasms; Probiotics; Prodrugs; Tumor Burden; Vidarabine Phosphate

2016